test44
https://www.cytel.com/blog/what-is-ahead-for-clinical-trial-design
January 19, 2022
The past two years have been transformative for Cytel. Most notably, the global COVID-19 pandemic unleashed an..
Read article
test44
https://www.cytel.com/blog/bayesian-methods-for-multiple-cohort-expansion-design
November 16, 2020
MUCE is a Bayesian solution for cohort expansion trials where multiple dose(s) and multiple indication(s) are tested in..
Read article
test44
https://www.cytel.com/blog/key-design-considerations-for-platform-trials
November 10, 2020
Platform trials are a new type of clinical trials where multiple interventions can be evaluated simultaneously against..
Read article
test44
https://www.cytel.com/blog/innovative-trial-design-video-resources
January 26, 2018
The Cytel YouTube Channel hosts a wealth of video presentations from Cytel experts as well as external industry and..
Read article
test44
https://www.cytel.com/blog/design-monitoring-multi-arm-multi-stage-trials
March 29, 2017
With an increasing interest in platform designs and other innovative designs that involve multiple comparisons over..
Read article
test44
https://www.cytel.com/blog/learning-from-less-well-understood-adaptive-designs
September 29, 2016
A paper "Best practices case studies for 'less well-understood' Adaptive designs", has been published by the DIA..
Read article
test44
https://www.cytel.com/blog/east-6.4-release-interview-with-yannis-jemiai
May 31, 2016
Last week, we were delighted to announce the release of East 6.4 bringing further cutting –edge approaches to the..
Read article
test44
https://www.cytel.com/blog/east-multi-arm-multi-stage-part1
March 11, 2016
There has been increasing interest in multi-arm multi-stage trials with treatment selection and sample size..
Read article
test44
https://www.cytel.com/blog/leveraging-the-flexibility-of-an-adaptive-clinical-trials-a-case-study
March 27, 2015
We have often said that one of the greatest benefits of an adaptive clinical trial is the flexibility it affords for..
Read article